biomavenO...they have announced that they will release more phase II second line NSCLC data at the Chicago Thoracic Oncology Conference on Sept. 7...that will indeed be of great interest....and not too long to wait!
As for the ATM...I understand your concern...but I overcame mine and made a nice 500% gain in the past few weeks. They indicate they want to partner prior to the end of phase II meeting with the FDA(a partner would want to be there!). They say they have a number of BP's interested since the second line phase II NSCLC data has begun to mature. If the data continues to look good I think the upfront,milestone and royalty payments of a partnership will make ATM financing a thing of the past!
Market Data 
Markets 
AI
